Snowden Capital Advisors LLC reduced its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,213 shares of the semiconductor company’s stock after selling 69 shares during the quarter. Snowden Capital Advisors LLC’s holdings in Synopsys were worth $589,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Whipplewood Advisors LLC bought a new stake in shares of Synopsys during the fourth quarter valued at approximately $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Synopsys during the fourth quarter valued at approximately $34,000. Sierra Ocean LLC bought a new stake in shares of Synopsys during the fourth quarter valued at approximately $39,000. Hazlett Burt & Watson Inc. grew its stake in shares of Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company’s stock valued at $44,000 after purchasing an additional 20 shares during the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC grew its stake in shares of Synopsys by 50.8% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company’s stock valued at $48,000 after purchasing an additional 33 shares during the last quarter. 85.47% of the stock is owned by institutional investors.
Synopsys Stock Performance
SNPS opened at $515.61 on Wednesday. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $624.80. The firm’s fifty day moving average is $447.85 and its two-hundred day moving average is $489.13. The firm has a market cap of $79.72 billion, a PE ratio of 35.51, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16.
Insider Buying and Selling
Wall Street Analyst Weigh In
SNPS has been the topic of a number of recent research reports. Morgan Stanley reduced their price objective on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a research note on Monday, February 24th. Stifel Nicolaus set a $550.00 price objective on shares of Synopsys in a research note on Monday, April 28th. Bank of America reduced their price objective on shares of Synopsys from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. Piper Sandler reduced their price objective on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Finally, Wells Fargo & Company reduced their price objective on shares of Synopsys from $540.00 to $520.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 27th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $614.86.
View Our Latest Stock Analysis on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- Stock Analyst Ratings and Canadian Analyst Ratings
- Top 5 Stocks Hedge Funds Are Buying Right Now
- The Most Important Warren Buffett Stock for Investors: His Own
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- How to Calculate Inflation Rate
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.